Skip to main content
Erschienen in: Tumor Biology 4/2015

01.04.2015 | Research Article

Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case–control study

verfasst von: Xiaodong Zhao, Tianyi Wang, Bo Liu, Zhenzhou Wu, Shuo Yu, Tao Wang

Erschienen in: Tumor Biology | Ausgabe 4/2015

Einloggen, um Zugang zu erhalten

Abstract

Hepatocellular carcinoma (HCC) is one of the most common cancers worldwide with high mortality rate. Upstream transcription factor 1 (USF1) is a ubiquitously expressed transcription factor that regulates the expression of genes involving in different biological processes, including cancer. The aim of this study is to examine the correlation between USF1 polymorphisms and HCC susceptibility. Ninety-four HCC patients and 100 healthy volunteers are recruited in our study. Tag single nucleotide polymorphisms (Tag-SNPs) were retrieved in the International HapMap Project Databases. Extraction of genomic DNAs was conducted with TaqMan Blood DNA kits. Genotyping of USF1 polymorphisms were carried out with TaqMan SNPs genotyping assay. Odds ratios (ORs) and their 95 % confidence intervals (CIs) were calculated to evaluate the association between USF1 polymorphisms and HCC risk. All statistical analyses were performed with SPSS 20.0 software. Five tag-SNPs were identified to represent the genetic variants of USF1. Our results suggested that rs2516839 in the 5′UTR of USF1 was significantly associated with increased HCC risk (AA vs GG: OR = 3.15; 95 % CI 1.44–6.87; P = 0.003; GA + AA vs AA: OR = 1.85; 95 % CI 1.04–3.30; P = 0.034; AA vs GG + GA: OR = 2.96; 95 % CI 1.40–6.26; P = 0.004; A vs G: OR = 2.09; 9 % CI 1.35–3.23; P < 0.001). Although rs2073655 in the intron region of USF1 was also shown to be correlated with decreased HCC susceptibility in recessive model (TT vs CC + CT: OR = 0.40; 95 % CI 0.54–0.75; P = 0.004), this association was not conclusive. Our results indicated that the SNP of rs2516839 have close association with increased risk of HCC. Further studies may be needed to validate our results and gain insights into the pathological mechanism of USF1 gene in the HCC tumorigenesis.
Literatur
1.
2.
Zurück zum Zitat Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin. 2011;61:69–90.CrossRefPubMed
3.
Zurück zum Zitat El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.CrossRefPubMed El–Serag HB, Rudolph KL. Hepatocellular carcinoma: epidemiology and molecular carcinogenesis. Gastroenterology. 2007;132:2557–76.CrossRefPubMed
4.
Zurück zum Zitat Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.CrossRefPubMed Perz JF, Armstrong GL, Farrington LA, Hutin YJ, Bell BP. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. J Hepatol. 2006;45:529–38.CrossRefPubMed
5.
Zurück zum Zitat Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7:599–612.CrossRefPubMed Seitz HK, Stickel F. Molecular mechanisms of alcohol-mediated carcinogenesis. Nat Rev Cancer. 2007;7:599–612.CrossRefPubMed
6.
Zurück zum Zitat Santella RM, Wu HC. Environmental exposures and hepatocellular carcinoma. J Clin Transl Hepatol. 2013;1:138–43.PubMedPubMedCentral Santella RM, Wu HC. Environmental exposures and hepatocellular carcinoma. J Clin Transl Hepatol. 2013;1:138–43.PubMedPubMedCentral
7.
Zurück zum Zitat Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52:252–7.CrossRefPubMed Dragani TA. Risk of HCC: genetic heterogeneity and complex genetics. J Hepatol. 2010;52:252–7.CrossRefPubMed
8.
Zurück zum Zitat Baron Y, Corre S, Mouchet N, Vaulont S, Prince S, Galibert M-D. USF1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions. PLoS Genet. 2012;8:e1002470.CrossRefPubMedPubMedCentral Baron Y, Corre S, Mouchet N, Vaulont S, Prince S, Galibert M-D. USF1 is critical for maintaining genome integrity in response to UV-induced DNA photolesions. PLoS Genet. 2012;8:e1002470.CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Ikeda R, Nishizawa Y, Tajitsu Y, Minami K, Mataki H, Masuda S, et al. Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells. Oncol Rep. 2014;31:197–201. doi:10.3892/or.2013.2818.PubMed Ikeda R, Nishizawa Y, Tajitsu Y, Minami K, Mataki H, Masuda S, et al. Regulation of major vault protein expression by upstream stimulating factor 1 in SW620 human colon cancer cells. Oncol Rep. 2014;31:197–201. doi:10.​3892/​or.​2013.​2818.PubMed
10.
Zurück zum Zitat Wu S, Mar-Heyming R, Dugum EZ, Kolaitis NA, Qi H, Pajukanta P, et al. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice. Hum Mol Genet. 2010;19:597–608. doi:10.1093/hmg/ddp526.CrossRefPubMed Wu S, Mar-Heyming R, Dugum EZ, Kolaitis NA, Qi H, Pajukanta P, et al. Upstream transcription factor 1 influences plasma lipid and metabolic traits in mice. Hum Mol Genet. 2010;19:597–608. doi:10.​1093/​hmg/​ddp526.CrossRefPubMed
11.
12.
Zurück zum Zitat Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, et al. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet. 2004;13:1587–97. doi:10.1093/hmg/ddh168.CrossRefPubMed Putt W, Palmen J, Nicaud V, Tregouet DA, Tahri-Daizadeh N, Flavell DM, et al. Variation in USF1 shows haplotype effects, gene:gene and gene:environment associations with glucose and lipid parameters in the European Atherosclerosis Research Study II. Hum Mol Genet. 2004;13:1587–97. doi:10.​1093/​hmg/​ddh168.CrossRefPubMed
13.
Zurück zum Zitat Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36:371–6. doi:10.1038/ng1320.CrossRefPubMed Pajukanta P, Lilja HE, Sinsheimer JS, Cantor RM, Lusis AJ, Gentile M, et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet. 2004;36:371–6. doi:10.​1038/​ng1320.CrossRefPubMed
14.
Zurück zum Zitat Lee JC, Weissglas-Volkov D, Kyttala M, Sinsheimer JS, Jokiaho A, de Bruin TW, et al. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease. Arterioscler Thromb Vasc Biol. 2007;27:2222–7. doi:10.1161/ATVBAHA.107.151530.CrossRefPubMed Lee JC, Weissglas-Volkov D, Kyttala M, Sinsheimer JS, Jokiaho A, de Bruin TW, et al. USF1 contributes to high serum lipid levels in Dutch FCHL families and U.S. whites with coronary artery disease. Arterioscler Thromb Vasc Biol. 2007;27:2222–7. doi:10.​1161/​ATVBAHA.​107.​151530.CrossRefPubMed
15.
Zurück zum Zitat Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005;117:444–51. doi:10.1007/s00439-005-1340-x.CrossRefPubMed Coon H, Xin Y, Hopkins PN, Cawthon RM, Hasstedt SJ, Hunt SC. Upstream stimulatory factor 1 associated with familial combined hyperlipidemia, LDL cholesterol, and triglycerides. Hum Genet. 2005;117:444–51. doi:10.​1007/​s00439-005-1340-x.CrossRefPubMed
16.
Zurück zum Zitat Holzapfel C, Baumert J, Grallert H, Müller A, Thorand B, Khuseyinova N, et al. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case–cohort study, 1984–2002. Eur J Endocrinol. 2008;159:407–16.CrossRefPubMed Holzapfel C, Baumert J, Grallert H, Müller A, Thorand B, Khuseyinova N, et al. Genetic variants in the USF1 gene are associated with low-density lipoprotein cholesterol levels and incident type 2 diabetes mellitus in women: results from the MONICA/KORA Augsburg case–cohort study, 1984–2002. Eur J Endocrinol. 2008;159:407–16.CrossRefPubMed
17.
Zurück zum Zitat Laurila P-P, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:346–52.CrossRefPubMed Laurila P-P, Naukkarinen J, Kristiansson K, Ripatti S, Kauttu T, Silander K, et al. Genetic association and interaction analysis of USF1 and APOA5 on lipid levels and atherosclerosis. Arterioscler Thromb Vasc Biol. 2010;30:346–52.CrossRefPubMed
18.
Zurück zum Zitat Kristiansson K, Ilveskoski E, Lehtimäki T, Peltonen L, Perola M, Karhunen PJ. Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:983–9.CrossRefPubMedPubMedCentral Kristiansson K, Ilveskoski E, Lehtimäki T, Peltonen L, Perola M, Karhunen PJ. Association analysis of allelic variants of USF1 in coronary atherosclerosis. Arterioscler Thromb Vasc Biol. 2008;28:983–9.CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet. 2005;14:2595–605.CrossRefPubMed Naukkarinen J, Gentile M, Soro-Paavonen A, Saarela J, Koistinen HA, Pajukanta P, et al. USF1 and dyslipidemias: converging evidence for a functional intronic variant. Hum Mol Genet. 2005;14:2595–605.CrossRefPubMed
21.
Zurück zum Zitat Pezzolesi MG, Zbuk KM, Waite KA, Eng C. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Hum Mol Genet. 2007;16:1058–71. doi:10.1093/hmg/ddm053.CrossRefPubMed Pezzolesi MG, Zbuk KM, Waite KA, Eng C. Comparative genomic and functional analyses reveal a novel cis-acting PTEN regulatory element as a highly conserved functional E-box motif deleted in Cowden syndrome. Hum Mol Genet. 2007;16:1058–71. doi:10.​1093/​hmg/​ddm053.CrossRefPubMed
22.
23.
Zurück zum Zitat McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol. 2003;77:9852–61.CrossRefPubMedPubMedCentral McMurray HR, McCance DJ. Human papillomavirus type 16 E6 activates TERT gene transcription through induction of c-Myc and release of USF-mediated repression. J Virol. 2003;77:9852–61.CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Chang JT, Yang HT, Wang TC, Cheng AJ. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Mol Carcinog. 2005;44:183–92. doi:10.1002/mc.20129.CrossRefPubMed Chang JT, Yang HT, Wang TC, Cheng AJ. Upstream stimulatory factor (USF) as a transcriptional suppressor of human telomerase reverse transcriptase (hTERT) in oral cancer cells. Mol Carcinog. 2005;44:183–92. doi:10.​1002/​mc.​20129.CrossRefPubMed
25.
Zurück zum Zitat Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, et al. USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J. 2007;54:275–85.CrossRefPubMed Jung HS, Kim KS, Chung YJ, Chung HK, Min YK, Lee MS, et al. USF inhibits cell proliferation through delay in G2/M phase in FRTL-5 cells. Endocr J. 2007;54:275–85.CrossRefPubMed
26.
Zurück zum Zitat Luo X, Sawadogo M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci U S A. 1996;93:1308–13.CrossRefPubMedPubMedCentral Luo X, Sawadogo M. Antiproliferative properties of the USF family of helix-loop-helix transcription factors. Proc Natl Acad Sci U S A. 1996;93:1308–13.CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.CrossRefPubMed Farazi PA, DePinho RA. Hepatocellular carcinoma pathogenesis: from genes to environment. Nat Rev Cancer. 2006;6:674–87.CrossRefPubMed
28.
Zurück zum Zitat Kwok P-Y. Single nucleotide polymorphisms. Totowa, NJ: Humana; 2003. Kwok P-Y. Single nucleotide polymorphisms. Totowa, NJ: Humana; 2003.
30.
Zurück zum Zitat Rada-Iglesias A, Ameur A, Kapranov P, Enroth S, Komorowski J, Gingeras TR, et al. Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res. 2008;18:380–92. doi:10.1101/gr.6880908.CrossRefPubMedPubMedCentral Rada-Iglesias A, Ameur A, Kapranov P, Enroth S, Komorowski J, Gingeras TR, et al. Whole-genome maps of USF1 and USF2 binding and histone H3 acetylation reveal new aspects of promoter structure and candidate genes for common human disorders. Genome Res. 2008;18:380–92. doi:10.​1101/​gr.​6880908.CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med. 2004;10:362–5.CrossRefPubMed Shoulders CC, Naoumova RP. USF1 implicated in the aetiology of familial combined hyperlipidaemia and the metabolic syndrome. Trends Mol Med. 2004;10:362–5.CrossRefPubMed
32.
Zurück zum Zitat Singmann P, Baumert J, Herder C, Meisinger C, Holzapfel C, Klopp N, et al. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome. Obes Facts. 2009;2:235–42.CrossRefPubMedPubMedCentral Singmann P, Baumert J, Herder C, Meisinger C, Holzapfel C, Klopp N, et al. Gene-gene interaction between APOA5 and USF1: two candidate genes for the metabolic syndrome. Obes Facts. 2009;2:235–42.CrossRefPubMedPubMedCentral
33.
Zurück zum Zitat Lee S-K, Kim H-J, Kim B-J, Jo Y-S, Park K-S, Baik H-W, et al. Body mass index is associated with USF1 haplotype in Korean premenopausal women. J Korean Med Sci. 2008;23:83–8.CrossRefPubMedPubMedCentral Lee S-K, Kim H-J, Kim B-J, Jo Y-S, Park K-S, Baik H-W, et al. Body mass index is associated with USF1 haplotype in Korean premenopausal women. J Korean Med Sci. 2008;23:83–8.CrossRefPubMedPubMedCentral
34.
Zurück zum Zitat Jaiswal AS, Narayan S. Upstream stimulating factor‐1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene. J Cell Biochem. 2001;81:262–77.CrossRefPubMed Jaiswal AS, Narayan S. Upstream stimulating factor‐1 (USF1) and USF2 bind to and activate the promoter of the adenomatous polyposis coli (APC) tumor suppressor gene. J Cell Biochem. 2001;81:262–77.CrossRefPubMed
37.
Zurück zum Zitat Reisman D, Rotter V. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 1993;21:345–50.CrossRefPubMedPubMedCentral Reisman D, Rotter V. The helix-loop-helix containing transcription factor USF binds to and transactivates the promoter of the p53 tumor suppressor gene. Nucleic Acids Res. 1993;21:345–50.CrossRefPubMedPubMedCentral
Metadaten
Titel
Significant association between upstream transcription factor 1 rs2516839 polymorphism and hepatocellular carcinoma risk: a case–control study
verfasst von
Xiaodong Zhao
Tianyi Wang
Bo Liu
Zhenzhou Wu
Shuo Yu
Tao Wang
Publikationsdatum
01.04.2015
Verlag
Springer Netherlands
Erschienen in
Tumor Biology / Ausgabe 4/2015
Print ISSN: 1010-4283
Elektronische ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2871-3

Weitere Artikel der Ausgabe 4/2015

Tumor Biology 4/2015 Zur Ausgabe

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.